Frequently altered pathways in cancers involve tyrosine and serine/threonine kinases and relevant receptors, including the epidermal growth factor receptor (EGFR), which alter the regulation of Ras oncogenes overexpressed in glioblastoma (Cancer Genome Atlas Research, 2008). This evidence concerns the gene EGFR and cancer.